Announcements Trials
Browse Landscape

Phase

Phase 2 49Phase 1/2 14Phase NA 10Phase 3 6Phase 1 4Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 3

Status

Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Pancreatic Neoplasms 2Colorectal Cancer Metastatic 1

Interventions

Magnetic Resonance Spectroscopy 11Oxaliplatin 9Fluorouracil 9Leucovorin 7Irinotecan 7Gemcitabine 7Nivolumab 6Biopsy 6Bevacizumab 6pembrolizumab 5lenvatinib 5Specimen Handling 5Radiosurgery 5Cisplatin 5Capecitabine 5X-Rays 4Radiation 4Proflavine 4Oncolytic Virotherapy 4Cyclophosphamide 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4sodium thiosulfate 3gallium 68 PSMA-11 3folfirinox 3Surgical Procedures, Operative 3Paclitaxel 3Omeprazole 3Ketamine 3Immune Checkpoint Inhibitors 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Immune Checkpoint Inhibitors × Gastrointestinal × Clear all
NCT07486492 2026-03-20

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

The First Affiliated Hospital of Xiamen University

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

NCT06496373 2025-11-17

Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer

Ruijin Hospital

Phase EARLY_PHASE1 Recruiting
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

Jinling Hospital, China

Phase EARLY_PHASE1 Recruiting
12 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡